Skip to content

Unusual Machines UMAC Proceeds From Warrant Exercises

Proceeds From Warrant Exercises at other companies

BillionToOne, Inc.
 logo
BillionToOne, Inc. BLLN
$6.25K
NextNav logo
NextNavNN
$13K-97.5%
SoundHound AI, Inc. logo
SoundHound AI, Inc.SOUN
$0-100%
Grindr logo
GrindrGRND
$0-100%
TRV
Trevi Therapeutics, Inc.TRVI
$2.54M
Klaviyo logo
KlaviyoKVYO
$3K0.0%

Other financials

Income statement

See full
Revenue$8.1M+296%
Gross profit$2.7M+434%
Operating income-$7.3M-122%
Net income$10.3M+415%
EPS (diluted)$0.21+200%

Balance sheet

See full
Cash & equivalents$222.9M+4,358%
Total debt$3.3M+960%
Total equity$331.6M+1,986%
Total assets$339.7M+1,866%

Cash flow

See full
Operating cash flow-$17.4M-1,359%
CapEx$698.2K
Free cash flow-$18.1M-1,417%

Valuation

See full
Market cap$932.94M+337%
Enterprise value$713.33M+238%
P/S54.1×+23.5×

Profitability

See full
Gross margin35.1%+8.8pp
Operating margin-168.9%-46.9pp
Net margin-32.7%-15.8pp
FCF margin-232.8%

Returns & leverage

See full
Return on equity-3.2%-1.6pp
Debt / equity0.0×
Current ratio128.2×+121×

Where this comes from

Reported directly by Unusual Machines in its filing.

Tagged under the XBRL concept us-gaap:ProceedsFromWarrantExercises.

The official record: Unusual Machines’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →

Ask your AI about Unusual Machines's proceeds from warrant exercises.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Unusual Machines's proceeds from warrant exercises?
Unusual Machines (UMAC) reported proceeds from warrant exercises of $3.4M in Q1 2026.
How has Unusual Machines's proceeds from warrant exercises changed year-over-year?
Unusual Machines's proceeds from warrant exercises increased by 39.3% year-over-year, from $2.44M to $3.4M.
What does proceeds from warrant exercises mean?
This metric represents the cash inflows received by the company when holders of warrants exercise their right to purchase common stock at a predetermined price. It serves as a measure of potential equity dilution and provides a source of non-dilutive capital that strengthens the balance sheet. Investors monitor this to assess the conversion activity of derivative instruments and the resulting impact on total shares outstanding.